NasdaqGS - Delayed Quote • USD
Medpace Holdings, Inc. (MEDP)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:49 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 6 | 6 | 7 | 7 |
Avg. Estimate | 2.53 | 2.69 | 11.21 | 13.09 |
Low Estimate | 2.43 | 2.6 | 11.07 | 12.76 |
High Estimate | 2.59 | 2.78 | 11.41 | 13.45 |
Year Ago EPS | 1.93 | 2.22 | 8.88 | 11.21 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 6 | 6 | 7 | 7 |
Avg. Estimate | 528.83M | 554.83M | 2.17B | 2.52B |
Low Estimate | 523.3M | 547.09M | 2.16B | 2.45B |
High Estimate | 530.5M | 563.34M | 2.18B | 2.56B |
Year Ago Sales | 460.87M | 492.5M | 1.89B | 2.17B |
Sales Growth (year/est) | 14.70% | 12.70% | 15.00% | 16.10% |
Earnings History
CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
---|---|---|---|---|
EPS Est. | 1.91 | 2.05 | 2.22 | 2.46 |
EPS Actual | 1.93 | 2.22 | 2.46 | 3.2 |
Difference | 0.02 | 0.17 | 0.24 | 0.74 |
Surprise % | 1.00% | 8.30% | 10.80% | 30.10% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 2.53 | 2.69 | 11.21 | 13.09 |
7 Days Ago | 2.53 | 2.71 | 10.61 | 12.69 |
30 Days Ago | 2.53 | 2.71 | 10.62 | 12.68 |
60 Days Ago | 2.53 | 2.72 | 10.65 | 12.67 |
90 Days Ago | 2.41 | 2.56 | 9.96 | 11.84 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | 4 | 2 | 7 | 6 |
Up Last 30 Days | 5 | 2 | 7 | 6 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | 1 | 3 | -- | 1 |
Growth Estimates
CURRENCY IN USD | MEDP | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 31.10% | -- | -- | 6.50% |
Next Qtr. | 21.20% | -- | -- | 12.00% |
Current Year | 26.20% | -- | -- | 5.30% |
Next Year | 16.80% | -- | -- | 13.10% |
Next 5 Years (per annum) | 17.91% | -- | -- | 11.09% |
Past 5 Years (per annum) | 34.23% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Maintains | Guggenheim: Buy to Buy | 4/24/2024 |
Maintains | Baird: Outperform to Outperform | 4/24/2024 |
Upgrade | Jefferies: Hold to Buy | 4/23/2024 |
Initiated | Deutsche Bank: Hold | 3/18/2024 |
Maintains | UBS: Buy to Buy | 3/8/2024 |
Upgrade | UBS: Neutral to Buy | 2/15/2024 |
Related Tickers
ICLR ICON Public Limited Company
308.31
+2.74%
TMO Thermo Fisher Scientific Inc.
573.60
+0.33%
DHR Danaher Corporation
246.58
+0.32%
IDXX IDEXX Laboratories, Inc.
499.30
+2.06%
IQV IQVIA Holdings Inc.
234.88
+0.38%
DGX Quest Diagnostics Incorporated
134.26
-0.86%
LH Laboratory Corporation of America Holdings
198.40
+0.03%
MTD Mettler-Toledo International Inc.
1,238.09
+0.42%
CRL Charles River Laboratories International, Inc.
229.03
+0.54%
GH Guardant Health, Inc.
17.35
+1.11%